Peer-reviewed veterinary case report
Why some cat owners choose or avoid radioiodine for hyperthyroidism
By De Voogt, Charlotte et al.·Published in Journal of feline medicine and surgery·2023·Small Animal Department·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Radioiodine treatment in hyperthyroid cats: insights into the characteristics of owners and their cats, and owner motivation and perceptions.
- Species:
- cat
Plain-English summary
A group of cat owners whose pets were diagnosed with hyperthyroidism (an overactive thyroid) shared their experiences after their cats received radioiodine treatment, which is often a successful and less invasive option. Many owners switched to this treatment because they found it hard to give their cats medication or were unhappy with previous treatments. While most owners felt satisfied with the results, some expressed concerns about communication with their vets and the stress of having their cats hospitalized. Overall, the study highlights the need for better communication between vets and pet owners regarding treatment options and what to expect during the process.
People also search for: cat hyperthyroidism treatment · radioiodine therapy for cats · why is my cat losing weight · cat medication side effects · cat thyroid treatment options
Abstract
OBJECTIVES: Radioiodine (I) therapy is the most appropriate treatment option for many hyperthyroid cats, as it is minimally invasive and often curative. Nevertheless,I treatment is not always pursued by owners. Hence, it is important to obtain more insight into owner satisfaction during and afterI treatment, and their decision-making process. In this study, we describe the characteristics of owners and their hyperthyroid cats referred forI therapy, and determine owners' motivation and how they experienced theI treatment of their cat. METHODS: A survey was sent to owners whose cats underwentI therapy (n = 1071) between 2010 and 2017 at Ghent University. The survey contained 35 questions with tick-box or free-text answer options concerning family situation, pet insurance, previous therapy, comorbidities, motivation forI therapy and owner perception of this treatment. RESULTS: In total, 438 owners completed 94% or more of the questionnaire. Over half of the cats (55%) had received previous medical, dietary or surgical treatment. Motivations for changing the initial therapy toI therapy included difficulties in administering medication (31%), insufficient improvement in clinical signs (23%), side effects (16%) and following the referring veterinarian's advice (16%). Almost a fifth of owners (18%) were not informed about the existence ofI therapy by their veterinarian and found information onI treatment online or through friends. Hospitalising their cat was very distressing for 17% of owners. Most owners (92%) were satisfied with the treatment. Reasons for dissatisfaction were insufficient communication, iatrogenic hypothyroidism, persistent hyperthyroidism and comorbidities post-treatment. CONCLUSIONS AND RELEVANCE: Our study stresses the importance of communication regarding the possible outcome ofI treatment, the importance of managing underlying comorbidities before treatment and anticipating the stress of owners during their cat's hospitalisation period. The results of this study could help in improving client communication when advising onI treatment.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/36744573/